NCT07342764

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-09Est. Completion: 2028-11

Enrollment target: 110 participants

Locations

Contact

Antipsychotic-induced Weight Gain (AIWG)

This phase 2, double blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics…

Bentonville, United StatesCompleted Jun 17, 2022

Antipsychotic-induced Weight Gain (AIWG)

This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics…

Bentonville, United StatesCompleted Jul 29, 2022

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.